Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Interim Management Statement

1 May 2014 07:00

RNS Number : 9946F
Kingspan Group PLC
01 May 2014
 



 

KINGSPAN GROUP PLC

Interim Management Statement

1st May 2014

 

Kingspan Group plc, the global leader in high performance insulation, building fabric and solar integrated building envelopes, is issuing this Interim Management Statement in advance of its Annual General Meeting which is being held today at 10.00am in Dublin.

 

Overall Kingspan has experienced a strong start to the year with Continental Europe showing tentative signs of recovery, and the UK market being relatively buoyant across all key sectors we serve. Group sales of €561m in the first four months were 8% ahead of prior year, or 9% ahead at constant exchange rates.

 

The general pick-up in activity in the UK, which we saw in the final quarter of 2013, has continued into the early part of 2014. The Benelux market has shown early signs of recovery although industry activity is at relatively low levels, and Germany remains solid. In North America, our Insulated Panel business continues to advance driven by market penetration gains, however there is limited evidence of a wider market recovery in that region. The Middle East continues to be quite active, and Australia started the year well as penetration continues to grow.

 

Insulated Panel sales revenues were up 14% (+16% constant currency) in the first four months with all key markets recording growth, reflecting both penetration gains and increased market activity, compounded by a mild winter in Europe. The sales performance also reflects a good first quarter from Kingspan Energy which should be well positioned to deliver its full year sales target. In February, we completed the acquisition of Dri-Design®, a high-end architectural façades business in the US with annual revenues of c. $25m.

 

Insulation Board sales revenues were 3% ahead (+3% constant currency) in the first four months reflecting a busier UK market and an improving environment in the Benelux, albeit off a low base. The Group's next generation Insulation, Optim-R®, entered production in the UK during the period, and a new insulation board facility in Burkhardtsdorf in eastern Germany is scheduled to be fully commissioned by mid-year.

 

Access Floor sales revenues were 9% behind (-7% constant currency) in the first four months. UK sales were ahead, driven by a lively London office market, countered by a US office environment which is stubbornly slow to recover. There is some evidence of a potential improvement in office activity in the US for 2015.

 

Environmental sales revenues in the four month period were in line with the same period last year, as the divisional activity enters a more stable phase.

 

Net debt at the 25th April was €124m an increase of €16m from the position at last year end reflecting, in part, the US façades acquisition for €23.2m. The Group's funding position is robust and, as announced recently, was further helped by the recent re-pricing and term extension of the Group's syndicated bank facility to March 2019.

 

The Board wishes to thank David Byrne and Brian Hill who will retire today as Non-Executive Directors. We are very grateful to both David and Brian for their counsel and contribution to the Board during the past nine years.

 

Looking ahead, the order backlog across the Group points towards a strong first half for the business, albeit somewhat complimented by a favourable quarter one comparative, ahead of a more demanding second quarter comparison. Activity levels generally across our markets are encouraging. We remain mindful of the prevailing geo-political uncertainty and its potential to upset what has so far been a relatively nebulous recovery. Notwithstanding this, growing conversion, a strong innovation pipeline, and the greater worldwide focus on energy efficiency, leaves us confident about Kingspan's longer term future.

 

Kingspan will issue its half-year financial report for the period ended 30 June 2014 on Tuesday 26 August 2014.

 

For further information contact:

Gene Murtagh, Chief Executive Officer Tel: +353 (0) 42 9698000

Geoff Doherty, Chief Financial Officer Tel: +353 (0) 42 9698000

Pat Walsh, Murray Consultants Tel: +353 (0) 1 4980300

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBLGDSRXXBGSG
Date   Source Headline
5th Apr 202212:49 pmRNSHolding(s) in Company
4th Apr 20229:51 amRNSHolding(s) in Company
1st Apr 20229:00 amRNSTotal Voting Rights
1st Apr 20227:00 amRNSHolding(s) in Company
30th Mar 20223:55 pmRNSDirector/PDMR Shareholding
28th Mar 20229:32 amRNSHolding(s) in Company
24th Mar 20226:09 pmRNSHolding(s) in Company
21st Mar 202212:00 pmRNSNotice of AGM
7th Mar 20226:06 pmRNSHolding(s) in Company
1st Mar 20227:00 amRNSTotal Voting Rights
24th Feb 20222:35 pmRNSDirector/PDMR Shareholding
24th Feb 20228:34 amRNSAnnual Financial Report
23rd Feb 20223:56 pmRNSDirector/PDMR Shareholding
18th Feb 20227:00 amRNSAcquisition
18th Feb 20227:00 amRNSFinal Results
27th Jan 20226:10 pmRNSHolding(s) in Company
27th Jan 20229:34 amRNSHolding(s) in Company
12th Jan 20225:01 pmRNSHolding(s) in Company
10th Jan 20223:22 pmRNSHolding(s) in Company
4th Jan 20229:00 amRNSBlock listing Interim Review
4th Jan 20228:00 amRNSTotal Voting Rights
9th Dec 202110:56 amRNSHolding(s) in Company
7th Dec 20214:15 pmRNSHolding(s) in Company
7th Dec 20219:17 amRNSHolding(s) in Company
1st Dec 20214:48 pmRNSTotal Voting Rights
22nd Nov 202110:14 amRNSHolding(s) in Company
8th Nov 20217:00 amRNSTrading Statement
1st Nov 20213:45 pmRNSTotal Voting Rights
6th Oct 202110:38 amRNSHolding(s) in Company
1st Oct 202111:17 amRNSTotal Voting Rights
1st Oct 202110:04 amRNSDirector Declaration
1st Oct 20219:23 amRNSHolding(s) in Company
10th Sep 20211:54 pmRNSDirector/PDMR Shareholding
8th Sep 20212:12 pmRNSDirector/PDMR Shareholding
1st Sep 202110:22 amRNSTotal Voting Rights
24th Aug 20212:49 pmRNSHolding(s) in Company
23rd Aug 20212:48 pmRNSDirector/PDMR Shareholding
20th Aug 20217:00 amRNSHalf-year Report
16th Aug 20219:53 amRNSHolding(s) in Company
22nd Jul 202110:42 amRNSHolding(s) in Company
7th Jul 20214:53 pmRNSHolding(s) in Company
6th Jul 20215:14 pmRNSHolding(s) in Company
6th Jul 20215:12 pmRNSHolding(s) in Company
1st Jul 202111:44 amRNSBlock listing Interim Review
1st Jul 202111:36 amRNSTotal Voting Rights
23rd Jun 20215:12 pmRNSHolding(s) in Company
22nd Jun 20217:00 amRNSTrading Statement
15th Jun 202112:49 pmRNSAcquisition Update
11th Jun 20216:36 pmRNSHolding(s) in Company
10th Jun 20215:35 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.